Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · March 24, 2015

Mortality Risk With Extended-Duration Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

The Lancet

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Mortality in Patients Treated With Extended Duration Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Pairwise and Bayesian Network Meta-Analysis of Randomised Trials
Lancet 2015 Mar 13;[EPub Ahead of Print], T Palmerini, U Benedetto, L Bacchi-Reggiani, DD Riva, G Biondi-Zoccai, F Feres, A Abizaid, MK Hong, BK Kim, Y Jang, HS Kim, KW Park, P Genereux, DL Bhatt, C Orlandi, S De Servi, M Petrou, C Rapezzi, GW Stone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading